BFC Planning’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$560 Buy
+31
New +$594 ﹤0.01% 3277

Other funds holding RLAY

BFC Planning's RLAY Position: Q3 2026 in Review

BFC Planning opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 31 shares worth $560. The stake represents ﹤0.01% of the portfolio and ranks #3277 among its holdings.

183 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • BFC Planning held 31 shares of Relay Therapeutics worth $560 as of Q3 2026.
  • Relay Therapeutics was a new BFC Planning position in Q3 2026.
  • Relay Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3277 holding.
  • 183 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.